Gastrojejunostomy as induction treatment for S-1-based chemotherapy in patients with incurable gastric cancer

Surgery Today

Volumn 38, Issue 12, 2008, Pages 1102-1107

  Ohashi, Manabu ^a,d   Kanda, Tatsuo ^a   Hirota, Masaki ^b   Kobayashi, Takashi ^c   Yajima, Kazuhito ^a   Kosugi, Shin Ichi ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Department of Surgery   (Japan)

^c Niigata Rinko Hospital   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Gastrojejunostomy; Incurable gastric cancer; Quality of life; S 1; Survival time

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; DOCETAXEL;

ADULT; AGED; ARTICLE; BLEEDING; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GASTRECTOMY; GASTROJEJUNOSTOMY; HUMAN; JAPAN; LAPAROTOMY; MALE; MONOTHERAPY; OPERATION DURATION; PATIENT SAFETY; QUALITY OF LIFE; STOMACH CANCER; STOMACH OBSTRUCTION; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; BLOOD LOSS, SURGICAL; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; FEMALE; GASTRIC BYPASS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OXONIC ACID; QUALITY OF LIFE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TEGAFUR;

EID: 57049128918     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3749-4     Document Type: Article

References (30)

1. The Research Group for Population-based Cancer Registration in Japan. 1998 Cancer incidence in Japan, 1985-89: re-estimation based on data from eight population-based cancer registries Jpn J Clin Oncol 28 54 67
2. P. Pisani D.M. Parkin F. Bray J. Ferlay 1999 Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 18 29
3. Nakajima T, Ohta K, Ohyama K. Tabular analysis of CIH (Cancer Institute Hospital) database. In: Nakajima T, Yamaguchi T, editors. Multimodality therapy for gastric cancer. Berlin Heidelberg New York Tokyo: Springer; 1999. p. 197-267.
4. H.B. Devine 1925 Basic principles and supreme difficulties in gastric surgery Surg Gynecol Obstet 40 1 16
5. K. Arai M. Kitamura Y. Iwasaki 1995 Usefulness of gastric exclusion for unresectable gastric cancer from the standpoint of postoperative quality of life and outcome (in Japanese with English abstract) Jpn J Gastrointestinal Surg 28 645 649
6. M. Kaminishi H. Yamaguchi N. Shimizu S. Nomura A. Yoshikawa M. Hashimoto 1997 Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma Arch Surg 132 184 187
7. S. Kikuchi O. Tsutsumi N. Kobayashi H. Tsukamoto H. Shimao Y. Sakakibara 1999 Does gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation? Hepato-Gastroenterology 46 584 587
8. S. Pyrhonen T. Kunitunen P. Nyandoto M. Kouri 1995 Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer Br J Cancer 71 587 591
9. B. Glimelius K. Hoffman U. Haglund O. Nyren P.O. Sjoden 1994 Initial or delayed chemotherapy with best supportive care in advanced gastric cancer Ann Oncol 5 189 190
10. A.M. Murad F.E. Santiago A. Petroianu P.R. Rocha M.A. Rodrigues M. Rausch 1993 Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37 41
11. Y. Sakata A. Ohtsu N. Horikoshi K. Sugimachi Y. Mitachi T. Taguchi 1999 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M Tegafur-0.4 M Gimestat-1 M Otastat Potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720
12. A. Ohtsu N. Boku F. Tamura K. Muro Y. Shimada K. Saigenji 1998 An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer Am J Clin Oncol 21 416 419
13. T. Taguchi Y. Sakata R. Kanamaru M. Kurihara M. Suminaga J. Ota 1998 Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A) (in Japanese with English abstract) Gan to Kagaku Ryoho 25 1915 1924
14. K. Futatsuki A. Wakui I. Nakao Y. Sakata M. Kambe Y. Shimada 1994 Late phase II study of irrinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group (in Japanese with English abstract) Gan to Kagaku Ryoho 21 1033 1038
15. W. Koizumi S. Tanabe K. Saigenji A. Ohtsu N. Boku F. Nagashima 2003 Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207 2212
16. E. Mochiki T. Ohno Y. Kamiyama R. Aihara N. Haga H. Ojima 2006 Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer Br J Cancer 95 1642 1647
17. K. Yoshida M. Ninomiya N. Takakura N. Hirabayashi W. Takiyama Y. Sato 2006 Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer Clin Cancer Res 12 3402 3407
18. M. Inokuchi T. Yamashita T. Yamada K. Kojima W. Ichikawa Z. Nihei 2006 Phase I/II study of S-1 combined with irrinotecan for metastatic advanced gastric cancer Br J Cancer 94 1130 1135
19. M.M. Oken R.H. Creech D.C. Tormey J. Horton T.E. Davis E.T. MacFadden 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 6 649 655
20. Japanese Gastric Cancer Association. 1998 Japanese classification of gastric carcinoma, 2nd English edition Gastric Cancer 1 10 24
21. P. Therasse S.G. Arbuck E.A. Eisenhauer J. Wanders R.S. Kaplan L. Rubinstein 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216
22. S.P.Y. Kwok S.C.S. Chung S.M. Griffin A.K.C. Li 1991 Devine exclusion for unresectable carcinoma of the stomach Br J Surg 787 684 685
23. Y. Nakata K. Kimura N. Tomioka M. Sato Y. Watanabe K. Kawachi 1999 Gastric exclusion for unresectable gastric cancer Hepatogastroenterology 46 2654 2657
24. S.J. Kwon H.G. Lee 2004 Gastric partitioning gastrojejunostomy in unresectable distal gastric cancer patients World J Surg 28 365 368
25. I. Chau A.R. Norman D. Cummingham J.S. Waters J. Oates P.J. Ross 2004 Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data J Clin Oncol 22 2395 2403
26. S. Kikuchi Y. Arai M. Morise N. Kobayashi H. Tsukamoto H. Shimao 1998 Gastric cancer with metastases to the distant peritoneum: A 20 year surgical experience Hepatogastroenterology 69 41 44
27. T. Yoshikawa M. Kanari A. Tsuburaya O. Kobayashi M. Sairenji H. Motohashi 2003 Should gastric cancer with peritoneal metastasis be treated surgically? Hepatogastroenterology 50 1712 1715
28. N. Boku A. Ohtsu Y. Shimada K. Shirao S. Seki H. Saito 1999 Phase II study of a combination of irrinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 17 319 323
29. M.M. Kim V. Rana N.A. Janjan P. Das A.T. Phan M.E. Delclos 2007 Clinical benefit of palliative radiation therapy in advanced gastric cancer Acta Oncol 26 1 7
30. I. Maetani S. Akatsuka M. Ikeda T. Tada T. Ukita Y. Nakamura 2005 Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomy J Gastroenterol 40 932 937